CALYPTE BIOMEDICAL CORP Share-based Payment Arrangement, Expense
CALYPTE BIOMEDICAL CORP reported Share-based Payment Arrangement, Expense of $8.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-06-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2014-06-24
- CALYPTE BIOMEDICAL CORP share-based payment arrangement, expense for fiscal 2012 was $8.00K.
| Period end | Share-based Payment Arrangement, Expense 12 month |
|---|---|
| 2012-12-31 | $8.00K 10-K · filed 2014-06-24 |